RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Subgroup Analysis of BENEFiT Trial to Evaluate Effect of Bosentan for Patients with CTEPH
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 5
SP 14
OP 15
DO 10.1177/155989770700700510
UL http://mdc.sagepub.com/content/7/5/14.abstract
AB This article discusses results of a pre-defined subgroup analysis from the bosentan for inoperable chronic thromboembolic pulmonary hypertension [BENEFiT] trial. The BENEFiT study is the first double-blind, placebo-controlled trial designed to evaluate the safety and efficacy of bosentan for patients with inoperable chronic thromboembolic pulmonary hypertension, one of the leading causes of pulmonary arterial hypertension.